Key result
Rautaharju-corrected QTc prolongation in LBBB predicts ~1% higher all-cause mortality risk per ms increase.
Why the study?
Identifying QT prolongation in LBBB is challenging, and the prognostic value of LBBB-specific QT correction formulas has not been conclusively established.
Does QTc interval prolongation predict all-cause mortality in patients with left bundle branch block?
Cohort (n=493)
No
Does QTc interval prolongation predict all-cause mortality in patients with left bundle branch block?
Answers are grounded in this paper and cite their sources.
In patients with left bundle branch block, QTc prolongation is a strong predictor of all-cause mortality, and the Rautaharju formula provides the best risk stratification.
QT prolongation is recognized as a prognostic marker associated with poor clinical outcomes and is frequently observed in patients with left bundle branch block (LBBB). However, the identification of QT prolongation in LBBB patients remains challenging. Although multiple QT correction formulas have been specifically developed for LBBB, the prognostic significance and predictive value of these corrected QT intervals in LBBB patients have not been conclusively established. This retrospective cohort study consecutively enrolled LBBB patients from 2011 to 2021. The exclusion criteria comprised patients with persistent atrial fibrillation/flutter, atrioventricular block, right ventricular pacing, atypical LBBB morphology and malignant tumor. Comprehensive data collection included electrocardiographic parameters, biochemical profiles, and clinical characteristics for all-cause mortality analysis. Five established QT correction (QTc) formulas (Rautaharju, Yankelson, Wang, Bogossian, and Colunga) were applied to calculate QTc intervals in LBBB patients. During a median follow-up time of 5.1 ± 2.9 years, the overall mortality rate was 21.50% (106/493), with differential rates observed between cardiology (18.32%, 74/404) and non-cardiology (35.96%, 32/89) subgroups. Multivariable regression analysis identified age, left ventricular ejection fraction, diabetes mellitus, and coronary artery disease as significant predictors of all-cause mortality following adjustment. Cardiac resynchronization therapy demonstrated consistent protective effects across all five analytical models constructed by each QTc formula. Furthermore, prolonged QTc interval calculated using all 5 formulas was significantly associated with increased mortality risk in multivariable analyses. Among the correction formulas, the Rautaharju formula exhibited superior predictive performance for all-cause mortality (AUC = 0.812, cut-off = 416.59 ms). In this retrospective cohort, patients with LBBB demonstrate substantially elevated mortality rates, particularly in non-cardiology populations, necessitating heightened clinical attention. While our findings demonstrate a robust association between QTc prolongation and all-cause mortality. Among the formulas evaluated, our study identifies the Rautaharju formula as the preferred tool for risk stratification in LBBB patients.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) conducted a cohort in Patients with left bundle branch block (LBBB) diagnosed by Strauss criteria, mean age 68.1 years, 46.45% female, mean LVEF 44.93%, including 31.85% with LVEF <35%, excluding patients with persistent atrial fibrillation/flutter, atrioventricular block, right ventricular pacing, atypical LBBB morphology, and malignant tumor (n=493). QT interval correction using Rautaharju formula vs. No QTc correction or other QTc formulas (Yankelson, Wang, Bogossian, Colunga) was evaluated on All-cause mortality (HR 1.011 per ms increase in QTc (Rautaharju), 95% CI 1.006-1.017, p=<0.001). QTc interval prolongation calculated using the Rautaharju formula predicted all-cause mortality with HR 1.011 per ms increase and AUC 0.812 in patients with LBBB over median 5.1 years follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: